Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$224,948
in 1 filing, $225K under 10b5-1 plans

Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McFarlane Neil F. −$225K President and CEO sold 5% of stake
Date Insider Transaction Shares Price Value Owned after
2016-08-17 Mickle Christal M M VP Prod Dev Purchase +5,000 $4.95 $25K 7,050
2016-08-17 Mickle Travis C President & CEO Purchase +5,000 $4.95 $25K 7,050
2016-05-24 Tierney David S Director Grant or award · Stock Option (right to buy) +10,000 10,000
2016-05-24 Thompson Danny L Director Grant or award · Stock Option (right to buy) +10,000 10,000
2016-05-24 Saluri Joseph Director Grant or award · Stock Option (right to buy) +10,000 10,000
2016-05-24 Plooster Matthew R Director Grant or award · Stock Option (right to buy) +10,000 10,000
2016-05-24 Pascoe Richard W Director Grant or award · Stock Option (right to buy) +10,000 10,000
2016-04-04 Thompson Danny L Director Exercise or conversion +13,333 $4.65 $62K 13,333
2016-04-04 Thompson Danny L Director Exercise or conversion · Stock Option (right to buy) −13,333 0
2016-03-29 Mickle Christal M M VP Prod Dev Purchase +400 $14.49 $6K 33,614
2016-03-29 Mickle Christal M M VP Prod Dev Purchase +2,050 $14.59 $30K 2,050
2016-03-29 Mickle Travis C President & CEO Purchase +2,050 $14.59 $30K 2,050
2016-03-29 Mickle Travis C President & CEO Purchase +400 $14.49 $6K 33,614
2016-02-11 Clifton R. LaDuane Chief Financial Officer & Sec Grant or award · Stock Option (right to buy) +50,000 50,000
2016-02-11 Guenther Sven Exec VP R&D Grant or award · Stock Option (right to buy) +50,000 50,000
2016-02-11 Woody Tracy M Chief Commercial Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2016-02-11 Johnson Gordon K Chief Business Officer Grant or award · Stock Option (right to buy) +50,000 50,000
2016-02-11 Mickle Christal M M VP Prod Dev Grant or award · Stock Option (right to buy) +20,000 20,000
2016-02-11 Mickle Christal M M VP Prod Dev Grant or award · Stock Option (right to buy) +150,000 150,000
2016-02-11 Mickle Travis C President & CEO Grant or award · Stock Option (right to buy) +150,000 150,000

Page 21 of 25 · 499 trades